UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000002761 |
|---|---|
| Receipt number | R000003272 |
| Scientific Title | Phase II trial of irinotecan with biweekly cetuximab in unresectable advanced and/or metastatic colorectal cancer, evaluation of the safety and efficacy based on EGFR positive and KRAS wild type.(i-BEX trial) |
| Date of disclosure of the study information | 2009/11/16 |
| Last modified on | 2014/05/23 17:16:01 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2009/11/13 10:23:12 | ||
| 2 | Update | 2010/02/16 13:28:42 | Public title Public title Acronym Acronym |
|
| 3 | Update | 2010/02/16 13:35:03 | Interventions/Control_1 |
|
| 4 | Update | 2010/02/16 13:52:31 | Organization Organization Nationality of Funding Organization |
|
| 5 | Update | 2013/08/01 11:56:23 | Post marketing survey by drug manufacture etc., specified by Japanese law. Tel1 Email1 |
|
| 6 | Update | 2014/05/23 17:16:01 | TEL TEL |
